 |
|
Preclinical results
Review - Conclusions drawn from experimental studies
Familiarity with different types of anti-cancer mechanisms can help to explain the tumour-inhibiting effect experienced in clinical trials. A better understanding and utilisation of these and other mechanisms would make a more effective and targeted field of application possible.
Avemar's anti-cancer effects were first demonstrated in animal experimental models which focused on tumour types widely used for the testing of anti-cancer agents, notably cytostatics. The results confirmed the evidence suggesting Avemar's anti-cancer activity.
» More
|
 |
|
 |
